3. Malaria
• Prevalence rate: 7.1% (Annual Report.
April 2018)
• WNBP – 30.8%
• Oro – 20.&%
• Madang – 18.4%
• New Ireland – 16.2%
• ENBP -11.4%
• Endemic in Papua New Guinea – first
cause of mortality and out-patient visits
5. Why is it common in
primigravida’s?
• Lack immunity to ‘pregnancy-
specific’ variants of P.F, that
selectively accumulate in the
placental intervillous space
leading to placental malaria
• Massive sequestration of infected
erythrocytes in placenta
6. Etiology
Caused by four species of plasmodium:
• P. falciparum - risk increases due to placental cytoadherence
• P. Vivax
• P. Ovale
prevalence and effect in pregnancy are unknown.
• P. Malariae
• P. Knowlesi – commonest cause of malaria in Malaysia
7. Mode of
transmission
• Bite from an anopheles
• Blood transfusion from an infected donor
• Sharing of infected needles and syringes
• Congenital transmission from mother to
child
11. In pregnant women: infected erythrocytes bind to chondroitin sulphate. A receptor present in the intervillous
space of the placenta, whereas in non-pregnant women infected erythrocytes adhere to CD36 and also exhibit
rosette formation and agglutination
12. Clinical
manifestations
Uncomplicated Malaria
Patients who present with symptoms
of malaria with +ve test but with no
features of severe malaria
• Fever
• Shivering/chills
• Headaches
• Muscle/joint pains
• Nausea/vomiting
• False labour pains
Complicated (Severe) Malaria
• Impaired consciousness (GCS<11/15)
• Prostation: GBW, unable to sit, stand or walk
• Multiple convulsions
• Severe Anaemia
• Jaundice
• Significant bleeding: haematemesis or malaena
• Pulmonary edema: chest indrawing with
crepitations on auscultation
• Metabolic: hypoglycaemia (<2.2mmol/L),
acidosis (base deficit > 8mEq/L or alctate >
5mmol/L)
• Shock
• Hyperparasitaemia (P.f > 10%)
14. Outcomes cont…
Complicated malaria
• Cerebral Malaria
• P.F blocks small vessels in the brain, induces fever, irritability, convulsions, and
sometimes episodes of coma
• Acute renal failure
• sudden reversible loss of function (days – weeks)
• ↓ GFR/perfusion: ↓ plasma vol, cardiogenic or septic shock
• Hyperkalaemia: due to ↓ GFR & acidosis)
• Intravascular hemolysis → Anaemia
15. What are the 3 components of a RED
BLOOD CELL???
GLOBIN
HEME
IRO
N
16. Oxidized
Diglucoronide
Monoglucoronide
RBCs
Globins
Irons
Cleared by mononuclear
Phagocytic system
Fe + transferrin
Hepatoglobin
Heme
Oxygenase
Biliverdin
Reductase
Hemes
Biliverdin
Unconjugated
Bilirubin
Conjugated
Bilirubin
Urobilinogen
Bilirubin +
Albumin
Bilirubin
+
Glucoronic Acid
SPLEEN LIVER GALL BLADDER
Responsible for the colour
of urine and stools
Urobilin
17. Oxidized
Diglucoronide
Monoglucoronide
RBC
s
Globin
s
Irons
Cleared by mononuclear
Phagocytic system
Fe +
transferrin
Hepatoglobin
Heme
Oxygenase
Biliverdin
Reductase
Heme
s
Biliverdin
Unconjugated
Bilirubin
Conjugated
Bilirubin
Urobilinogen
Bilirubin +
Albumin
Bilirubin
+
Glucoronic
Acid
SPLEE
N
LIVER GALL BLADDER
Responsible for the
colour of urine and
stools
Urobilin
How does malaria affect the break down of RBCs?
Hepatocellular
Damage
Splenomegaly
& splenic
rupture
Jaundice
(hemolytic)
Hyperbilirubinaemia
Pale stools
Urine appears dark
brown
Increased
Sequestration
Hemolytic Anaemia
21. Investigations:
• Rapid Malaria Test
• Detects Specific Malaria antigens (proteins) in
blood
• Can detect one or multiple malaria species
• Contains a strip made of filter paper & nitro-
cellulose: antibody binds to parasitic antigen
• Malaria Parasite Blood Slide (MPS)
• Involves staining and direct visualization of
parasite under microscope
• Others: Fluorescent Staining, PCR based Assay
and Antibody tests.
• Full Blood Examination
22. Treatment
• Depends on severity of the disease
• Uncomplicated
• Complicated or Severe
• Gestational Age: first, second and third trimester
• Aim: treat or resolve pyrexia.
23. WHO Guidance for Prevention and Treatment of Malaria in
Pregnancy
• Intermittent Preventive Treatment in pregnancy (IPTp)
• Sulfadoxine-pyrimethamine (fansidar)
• Commenced in the 2nd Trimester
• Each SP dose is given at least one month apart
• IPTp is administered as directly observed therapy (DOT)
• Insecticide-Treated nets (ITNs)
• Provided to women as early in the pregnancy
24. Treatment (P. falciparum or P. Ovale)
Uncomplicated Malaria Trimester 1 Trimester 2 & 3
Quinine 600mg IMI/PO TDS + Clindamycin
10mg/kg IMI BD x 7/7
If Treatment fails: Artesunate + clindamycin x 7/7
If clindamycin is unavailable, use quinine as a
monotherapy
Artemisinin-based combination therapy (ACT)
• Artesunate + amodiaquine
• Artesunate + mefloquine
• Dihydroartemisinin + piperaquine
• Artesunate + sulfadoxine-pyrimethamine (SP)
• Artemether +lumefantrine
Coartem/Mala-1 3tabs PO stat, 3tabs PO after 8h,
then BD x 3/7
Severe or Complicated Malaria Artesunate IMI/IVI x 24hrs
If artensunate is not available, use quinine or
artemether
Artesunate IMI/IVI x 24hrs
then
Artemether & lumefantrine
3tabs PO stat, 3tabs PO after 8h, then BD x 3/7
If a woman is either toxic or vomiting, use parenteral/rectal suppositories of coartem/artesunate or injections of quinine.
Avoid fansider before 16 weeks and after 34 weeks
25.
26. Mixed Infection
(p.falciparum,
ovale, malariae)
• Add primaquine 200mg PO dly x
14 days to the standard
treatment.
• Only to be commenced after
delivery provided the baby does
not have G6PD deficiency.
27. • Supportive Treatment:
• Fetal monitoring
• Adequate calories
• Correct electrolyte imbalance
• Blood transfusion
• Oxygen + diuretics in pulmonary edema
• Anticonvulsants
• Admission to Intensive care unit for complicated malaria
• Dialysis for acute renal failure (ARF)
28. Complicated Malaria in Pregnancy
• Maintain airway patency, insert guedals airway and nurse on lateral side
• Insert an intravenous cannula and collect bloods: BSL, FBE, MPS, UEC/LFT, x-
match, blood gases, lumbar puncture
• Perform a detailed clinical examination including GCS
• Insert an IDC – monitor fluid balance to avoid over or under hydration
29. Differential Diagnosis of fever in pregnant women
• Bacterial Meningitis
• Repiratory infections: Pulmonary TB or EPTB, pneumonia, URTI, Covid-19
• Cellulitis
• Urinary Tract infections: cystits, pyelonephritis
• Genital tract infections: vaginitis, cervicitis
30. Complicated Malaria in Pregnancy
Treating Complications
• IV Diazepam for convulsions
• Transfusion for severe anaemia
• Frusemide for pulmonary oedema
• IV glucose for hypoglycemia
• Fluid restriction, K-absorbing resins, IV potassium and insulin or dialysis for
renal failure
31. Preventive Measures
• Educate pregnant women to sleep under treated
bed nets
• Health Education
• Health awareness during ANC regarding
preventive strategies, i.e.
Use of treated bed nets
• Screened houses
• Protective clothing when outdoors
• Use of mosquito repellants
• Consistent ANC visits for malaria prophylaxis
• To seek medical attention if fever occurs.
• Rid off pools of stagnant water around the
vicinity of the house
32. Reference
• Gyal, K. et al. Malaria in Pregnancy, Intech open: Chapter 3. Available [online]. www.
http://dx.doi.org/10.5772/64611.com. Date Accessed [19th may 2019]
• Mola, G. and Maurice King.(2008) Primary Mother Care and Population for Papua New Guinea. UPNG
Press.
• Mola, G. Manual of Standard Managements in Obstetrics and Gynaecology for Doctors, HEO’s and Nurses in
Papua New Guinea.
• Royal College of Obstetricians and Gynaecologists . (March 2009) .The Treatment and Prevention of Malaria
in Pregnancy. Guideline No xx
• WHO. How malaria RDTs work [Online] Available: https://www.who.who.int/teams/global-malaria-
programme/case-management/diagnosis/rapid-diagnostic-tests/how-malaria-rdts-work Date accessed:
8.08.2022
• WHO (2007) Malaria in Pregnancy . Guidelines for measuring key monitoring and evaluation indicators
• WHO. How malaria RDTs work [Online] Available: https://www.who.who.int/teams/global-malaria-
programme/case-management/diagnosis/rapid-diagnostic-tests/how-malaria-rdts-work Date accessed:
8.08.2022
• WHO (2007) Malaria in Pregnancy . Guidelines for measuring key monitoring and evaluation indicators
Editor's Notes
1. HIV infection weakens the immunity and hampers the cytokine response to malaria.
During pregnancy, women develop antibodies to the infected erythrocyte surface that may either block infected erythrocyte binding or coat them for destruction by monocytes, thereby reducing disease severity in subsequent pregnancies
Anopheles injects its plasmodium sporozoites into the blood stream.
Carried to the liver, invade hepatic parenchymal cells and undergo asexual reproduction
A single sporozoite produces 10 000 to >30 000 merozoites.
Liver cell eventually bursts, thus discharging motile merozoites into the blood stream.
Merozoites invade RBCs and multiple 6-20 fold every 48-72hrs.
Merozoites that enter the blood stream, invade erythrocytes and become trophozoites.
By the end of the intraerythrocytic life cycle, the parasite has consumed all the haemoglobin, occupy most of the RBC, and is now called a schizont.
RBC ruptures and releases 6-30 merozoites, capable of invading other RBCs and repeating the cycle.
After a series of asexual cycles, some parasites develop into gametocytes that can transmit malaria.
.
Hypoglycemia: increased glucose metabolism and impaired glucose production caused by inhibition of gluconeogenesis
Quinine and quinidine – stimulants of pancreatic insulin secretion. This causes hyperinsulinemic hypoglycaemia
Lactic acidosis results from:
Failure of hepatic and renal clearance
anaerobic glycolysis in tissues
Lactate production by parasites
Acidosis: increased lactate production from anaerobic glycolysis and to a smaller extent from P.F
RDT: also referred to as a lateral flow immuno0-chromatographic antigen detection test.
Captures dye-labelled antibodies to produce a visible band on a strip of nitro-cellulose.
Dye-labelled antibody binds to parasite antigen – resulting complex is shown as a strip by a band bound antibody forming a visible line (T-test line)
A control line (c-control line) gives information on the integrity of the antibody-dye conjugate, but does not confirm the ability to detect parasite antigen
Procedure: mix blood with lysing agent (ruptures the BC, releasing more parasite protein)
There is not enough evidence for the alternative treatment using ACT in Trimester 1
Organogenesis occurs in T1, the period for potential teratogenicity. Hence antimalarials considered safe to use are quinine, chloroquine, clindamycin and proguanil.
Main objective: prevent patient mortality/morbidity
Secondary objective(s): prevent dissabilities and disease progression